The Reference Standard Rivaroxaban Glycolic Acid Analog (25 mg) is a high-quality reference material in accordance with United States Pharmacopeia standards. It has been specially developed to support quality assurance, validation and calibration in regulated pharmaceutical and biotechnological applications.

This reference material is ideal for analytical testing and ensures reliable and reproducible results in compliance with international regulatory requirements.